Activating and inhibitory FcγRs in autoimmune disorders

55Citations
Citations of this article
36Readers
Mendeley users who have this article in their library.

Abstract

Autoimmune disorders are characterized by the destruction of self-tissues by the immune system. Multiple checkpoints are in place to prevent autoreactivity under normal circumstances. Coexpression of activating and inhibitory Fc receptors (FcR) represents such a checkpoint by establishing a threshold for immune cell activation. In many human autoimmune diseases, however, balanced FcR expression is disturbed. Analysis of murine model systems provides strong evidence that aberrant FcR expression can result in uncontrolled immune responses and the initiation of autoimmune disease. This review will summarize this data and explain how this information might be used to better understand human autoimmune diseases and to develop novel therapeutic strategies. © 2006 Springer-Verlag.

Cite

CITATION STYLE

APA

Nimmerjahn, F. (2006, December). Activating and inhibitory FcγRs in autoimmune disorders. Springer Seminars in Immunopathology. https://doi.org/10.1007/s00281-006-0052-1

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free